Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research
Top Cited Papers
- 1 December 2013
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 100 (3) , 605-614
- https://doi.org/10.1016/j.antiviral.2013.09.028
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R01AI074986, R21AI107165)
- BMBF (01KI1005C)
- Leibniz Graduate School Emerging Infectious Diseases
This publication has 104 references indexed in Scilit:
- Human Betacoronavirus 2c EMC/2012–related Viruses in Bats, Ghana and EuropeEmerging Infectious Diseases, 2013
- Inhibitors of SARS-CoV entry – Identification using an internally-controlled dual envelope pseudovirion assayAntiviral Research, 2011
- Cell entry of enveloped virusesCurrent Opinion in Virology, 2011
- Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusionVirology, 2011
- A Small-Molecule Oxocarbazate Inhibitor of Human Cathepsin L Blocks Severe Acute Respiratory Syndrome and Ebola Pseudotype Virus Infection into Human Embryonic Kidney 293T cellsMolecular Pharmacology, 2010
- Elastase-mediated Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein at Discrete Sites within the S2 DomainJournal of Biological Chemistry, 2010
- Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sitesProceedings of the National Academy of Sciences, 2009
- Viral membrane fusionNature Structural & Molecular Biology, 2008
- Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entryProceedings of the National Academy of Sciences, 2008
- Identification of a new human coronavirusNature Medicine, 2004